ANNAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the year ended 2007 will be released on Monday, March 31, 2008.
PharmAthene management will be hosting a conference call to discuss its year end financial results. The call is scheduled to begin at 4:30 p.m. Eastern Time on Monday, March 31, 2008 and will last approximately 30 minutes.
The dial-in number within the United States is 866-700-6979. The dial-in number for international callers is 617-213-8836. The participant passcode is 29363875.
A replay of the conference call will be available for 30 days, beginning at approximately 6:30 p.m. Eastern Time March 31, 2008 until approximately 11:50 p.m. Eastern Time April 30, 2008. The dial-in number from within the United States is 888-286-8010. For international callers, the dial-in number is 617-801-6888. The participant passcode is 76157985.
The conference call will also be webcast and can be accessed from the company’s website at http://www.PharmAthene.com. A link to the webcast may be found on both the Home Page and also under the Investor Relations section of the website. The webcast will be available for 30 days, or until April 30, 2008.
About PharmAthene, Inc
PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene’s lead programs include Valortim(TM) for the prevention and treatment of anthrax infection and Protexia(R) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit http://www.PharmAthene.com.
CONTACT: Stacey Jurchison of PharmAthene, Inc., +1-410-269-2610,
JurchisonS@PharmAthene.com
Web site: http://www.pharmathene.com/
